Anti-Human IL12B Recombinant Antibody(Briakinumab)

Name: Anti-Human IL12B Recombinant Antibody(Briakinumab)
Brand: KMD Bioscience
SKU: YR1099

YR1099

科研级 Briakinumab ( 布雷奴单抗 ), Anti-IL12B Recombinant Antibody, Research Grade Briakinumab

DATASHEET MSDS

Product Description

Alias	科研级 Briakinumab ( 布雷奴单抗 ), Anti-IL12B Recombinant Antibody, Research Grade Briakinumab
Catalog Number	YR1099
Molecular Name	Briakinumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Lambda
Formulation	PBS, pH7.5
Background	Briakinumab (ABT-874) is a human monoclonal antibody being developed by Abbott Laboratories for the treatment of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. As of 2011 drug development for psoriasis has been discontinued in the U.S. and Europe.
CAS Number	339308-60-0
Application	FCM, IP, ELISA, Neut, FuncS
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Molecular Weight	146.5 kDa
Target	IL12B[Homo sapiens]

Login